Cognition Therapeutics, Inc. Common Stock (CGTX)

NASDAQ: CGTX • USD
0.73 USD
-0.33 (-30.47%)
AT CLOSE (11:59 AM EDT)
0.73
+0.00 (+0.00%)
POST MARKET (AS OF 07:59 PM EDT)
🔴Market: CLOSED
Open?$1.07
High?$1.07
Low?$0.68
Prev. Close?$0.73
Volume?7.1M
Avg. Volume?938.5K
VWAP?$0.83
Rel. Volume?7.60x
Bid / Ask
Bid?$0.69 × 400
Ask?$0.73 × 100
Spread?$0.04
Midpoint?$0.71
Valuation & Ratios
Market Cap?65.2M
Shares Out?89.4M
Float?79.6M
Float %?90.2%
P/E Ratio?N/A
P/B Ratio?1.90
EPS?-$0.26
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.43Strong
Quick Ratio?3.43Strong
Cash Ratio?2.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
1.90CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-0.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-68.5%WEAK▾
ROA?
-48.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$28.4M
Related Companies
Loading...
News
Profile
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Employees
14
Market Cap
65.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.cogrx.com
Listed
2021-10-08
Address
2500 WESTCHESTER AVE
PURCHASE, NY 10577
Phone: 412-481-2210
MarketsMoversWatchlist